R. Greither
Life Technologies
3 Papers
R. Greither is an academic researcher from Life Technologies. The author has contributed to research in topics: Biodosimetry & Medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Laboratory intercomparison of gene expression assays
Christophe Badie,Sylwia Kabacik,Yoganand Balagurunathan,Nordlinger Bernard,Muriel Brengues,Giovanni Faggioni,R. Greither,Florigio Lista,André Peinnequin,Thomas Poyot,F. Herodin,Andrew R. Missel,B. Terbrueggen,Frederic Zenhausern,Kai Rothkamm,Viktor Meineke,H. Braselmann,Christina Beinke,Michael Abend +18 more
TL;DR: In conclusion, gene expression-based dose estimates were reported quickly, and for laboratories with MAD between 0.3–0.5 Gy binary dose categories of clinical significance could be discriminated with an accuracy and sensitivity comparable to established cytogenetic assays.
Comparison of Established and Emerging Biodosimetry Assays
Kai Rothkamm,Christina Beinke,Horst Romm,Christophe Badie,Yoganand Balagurunathan,Stephen Barnard,N. Bernard,H. Boulay-Greene,Muriel Brengues,A. De Amicis,S. De Sanctis,R. Greither,F. Herodin,A. Jones,Sylwia Kabacik,T. Knie,Ulrike Kulka,Florigio Lista,Patrick Martigne,A. Missel,Jayne Moquet,Ursula Oestreicher,André Peinnequin,Thomas Poyot,U. Roessler,Harry Scherthan,B. Terbrueggen,Hubert Thierens,Marco Valente,Anne Vral,Frederic Zenhausern,Viktor Meineke,H. Braselmann,Michael Abend +33 more
TL;DR: The DCA has been confirmed as the gold standard biodosimetry method, but in situations where speed and throughput are more important than ultimate accuracy, the emerging rapid molecular assays have the potential to become useful triage tools.
Genome Sequencing of Wastewater Confirms the Arrival of the SARS-CoV-2 Omicron Variant at Frankfurt Airport but Limited Spread in the City of Frankfurt, Germany, in November 2021
Shelesh Agrawal,Laura Orschler,Simona Tavazzi,R. Greither,Bernd Manfred Gawlik,Susanne Lackner +5 more
TL;DR: Wastewater-based severe acute respiratory syndrome coronavirus 2 surveillance of Frankfurt Airport by genome sequencing was used to detect SARS-CoV-2 variants entering the region and all characteristic mutations of Omicron were found.